Atman Retreat Blog
Atman Retreat joins Odyssey: Psilocybin Retreats & Private Sessions Now Available in Oregon
We have exciting news - Atman Retreat is joining Odyssey!
Odyssey is a US public benefit corporation currently offering legal psilocybin retreats and private sessions in Oregon, with plans to expand to other states as regulations allow.
Here’s the press release with more information.
Continue reading to learn more about the context for this acquisition, Odyssey, and its psilocybin service offerings.
Oregon-Based Psilocybin Experiences Company Odyssey Acquires Atman Retreat to Fortify its Standards of Care & Operations
Originally posted at PRWeb
PORTLAND, Ore., March 21, 2024 /PRNewswire-PRWeb/ -- Odyssey, which became the first center to host a legal psilocybin retreat on U.S. soil in Fall 2023, is today announcing its acquisition of company Atman Retreat, which has offered psilocybin retreats since 2019. Atman founder, Aaron Nesmith-Beck will join the Odyssey team as interim COO, bringing years of expertise and a strong existing customer-base to Odyssey's mission in Oregon.
The Research-Backed Benefits of Psilocybin Retreats
Research on psychedelic therapy has been promising so far. Studies from institutions such as Imperial College London, Johns Hopkins, and NYU have found that two sessions with psilocybin plus psychological support can help alleviate various forms of emotional distress.
Because of the burgeoning research in this field, and the influx of media surrounding it, some people might have the impression that a psychedelic experience in a clinical or research context is the only safe and reliable way to experience the healing and transformative benefits of psychedelics.
However, psilocybin retreat participants often report the same sorts of changes as those seen in clinical trials. Moreover, many people aren’t aware that there is a growing body of evidence to support these claims.
Let’s explore what the latest research has to say about psilocybin retreats and then compare these findings to those of clinical trials.